During the past decade, Therapeutics Clinical Research conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 41 clinical trials were completed, i.e. on average, 89.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 23 clinical trials were completed. i.e. 153.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Therapeutics Clinical Research" #1 sponsor was "DUSA Pharmaceuticals, Inc." with 7 trials, followed by "Galderma R&D" with 6 trials sponsored, "Stiefel, a GSK Company" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Therapeutics, Inc." with 4 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Therapeutics Clinical Research" #1 collaborator was "GlaxoSmithKline" with 4 trials as a collaborator, "Therapeutics, Inc." with 4 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Accenture" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Therapeutics Clinical Research" are "Psoriasis" (16 trials), "Acne Vulgaris" (11 trials), "Actinic Keratosis" (10 trials), "Atopic Dermatitis" (7 trials) and "Plaque Psoriasis" (7 trials). Many other conditions were trialed in "Therapeutics Clinical Research" in a lesser frequency.

Most popular intervention types in "Therapeutics Clinical Research" are "Drug" (89 trials), "Other" (12 trials), "Device" (7 trials), "Biological" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Vehicle" (14 trials), "10% VDA-1102" (2 trials), "122-0551" (2 trials) and "ALA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Therapeutics Clinical Research" are 93 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Therapeutics Clinical Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Therapeutics Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Therapeutics Clinical Research, 10 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".